PERSPECTA

News from every angle

← Back to headlines

Intellia Therapeutics Stock Plummets, Cathie Wood Continues Buying

Intellia Therapeutics stock has fallen nearly 95% from its peak, yet investor Cathie Wood continues to acquire shares.

5 May, 18:05 — 5 May, 18:05
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual111d ago

Intellia Therapeutics Stock Is Down Nearly 95% From Its Record Highs but Cathie Wood Keeps Buying

Read full article →

Related Stories

US Treasury Considers Tapping $1 Trillion Account for Bond Buybacks

7h ago

Moody's Upgrades Pakistan's Sovereign Credit Rating to B3

8h ago

Shein Launches Hong Kong IPO at Reduced Valuation

10h ago

New Fed Chair Kevin Warsh Faces Early Test Amid Bond Market Concerns

15h ago